The company plans to ship components made at its plant in Shenzhen to Hong Kong where robots for overseas clients would be assembled
Shenzhen surgical robot start-up Yuanhua Tech plans to set up an assembly facility in Hong Kong to grow overseas sales and aims to float shares on the city’s bourse to fund development, according to its founder.
In 2022, the company received approval from China’s National Medical Products Administration to sell self-developed orthopaedic robot systems for total and partial knee and hip joint replacement surgeries, founder and chairwoman Li Aili said in an interview.
She expected that the firm, established in 2018, would receive approval next month to market its artificial disc replacement and trauma joint replacement surgery robots.
Your personal data will be processed and information from your device (cookies, unique identifiers, and other device data) may be stored by, accessed by and shared with 88 TCF vendor(s) and 20 ad partner(s), or used specifically by this site or app.
